|
End of Day Trades
|
1
|
Mannkind
|
Feb 28, 2013 04:13PM
|
|
Re: Philanthropist contributes $70 million to Nevada Community Foundation
|
3
|
Mannkind
|
Feb 28, 2013 04:11PM
|
|
Re: Patient Transitioning From Exubera®
|
1
|
Mannkind
|
Feb 27, 2013 09:18AM
|
|
Re: MannKind Trivia: Who Likes Word Problems
|
2
|
Mannkind
|
Feb 25, 2013 09:51AM
|
|
Re: Cowen and Company
|
|
Mannkind
|
Feb 20, 2013 03:40PM
|
|
Re: Monster Pre-market Trade
|
|
Mannkind
|
Feb 19, 2013 11:26AM
|
|
Monster Pre-market Trade
|
3
|
Mannkind
|
Feb 19, 2013 09:21AM
|
|
Re: CC Notes
|
|
Mannkind
|
Feb 12, 2013 09:19AM
|
|
Re: CC Adressed My #1 Concern
|
4
|
Mannkind
|
Feb 12, 2013 08:50AM
|
|
Novo CRL
|
1
|
Mannkind
|
Feb 11, 2013 09:10AM
|
|
Re: Game changer? Is trypanophobia a thing of the past?
|
1
|
Mannkind
|
Feb 05, 2013 05:23PM
|
|
Re: Game changer? Is trypanophobia a thing of the past?
|
|
Mannkind
|
Feb 05, 2013 02:55PM
|
|
Game changer? Is trypanophobia a thing of the past?
|
|
Mannkind
|
Feb 05, 2013 08:49AM
|
|
Re: MAP's Levadex Ready For FDA Approval
|
1
|
Mannkind
|
Feb 04, 2013 08:30AM
|
|
Re: Generex: Research For Sale On The Cheap
|
2
|
Mannkind
|
Jan 31, 2013 11:32AM
|
|
Re: Volume surge
|
1
|
Mannkind
|
Jan 31, 2013 09:27AM
|
|
Re: 2 Things to Watch at MannKind Corporation
|
|
Mannkind
|
Jan 30, 2013 08:14AM
|
|
Re: Afrezza Inhaled Insulin for Diabetes Mellitus
|
2
|
Mannkind
|
Jan 29, 2013 08:48AM
|
|
Re: NYT article: Precautions Urged for Drivers With Diabetes
|
3
|
Mannkind
|
Jan 29, 2013 08:27AM
|
|
Gun Control
|
2
|
Mannkind
|
Jan 17, 2013 04:53PM
|
